This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
The earlier detection of ovarian cancer using an mDETECT liquid biopsy
Using patient-derived models and drug sensitivity testing to guide personalized medicine: a proof-of-concept trial
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
Supercharging CAR-T cells for Ovarian Cancer
Building a scientific toolbox to study low-grade serous ovarian cancer
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
Understanding the experience of previvors receiving care at a specialized centre
Targeting epitranscriptomic mechanisms in ovarian cancer
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor